• 14695 Citations
  • 55 Scopus h-Index
1993 …2020

Research output per year

If you made any changes in Pure these will be visible here soon.

Research Output

Filter
Article
2020

Enhancing Brain Retention of a KIF11 Inhibitor Significantly Improves its Efficacy in a Mouse Model of Glioblastoma

Gampa, G., Kenchappa, R. S., Mohammad, A. S., Parrish, K. E., Kim, M., Crish, J. F., Luu, A., West, R., Hinojosa, A. Q., Sarkaria, J. N., Rosenfeld, S. S. & Elmquist, W. F., Dec 1 2020, In : Scientific reports. 10, 1, 6524.

Research output: Contribution to journalArticle

Open Access

Evaluating infusate parameters for direct drug delivery to the brainstem: A comparative study of convection-enhanced delivery versus osmotic pump delivery

Rechberger, J. S., Power, E. A., Lu, V. M., Zhang, L., Sarkaria, J. N. & Daniels, D. J., Jan 1 2020, In : Neurosurgical focus. 48, 1, E2.

Research output: Contribution to journalArticle

Open Access
1 Scopus citations

Genomic and phenotypic characterization of a broad panel of patient-derived xenografts reflects the diversity of glioblastoma

Vaubel, R. A., Tian, S., Remonde, D., Schroeder, M. A., Mladek, A. C., Kitange, G. J., Caron, A., Kollmeyer, T. M., Grove, R., Peng, S., Carlson, B. L., Ma, D. J., Sarkar, G., Evers, L., Decker, P. A., Yan, H., Dhruv, H. D., Berens, M. E., Wang, Q., Marin, B. M. & 14 others, Klee, E. W., Califano, A., LaChance, D. H., Eckel-Passow, J. E., Verhaak, R. G., Sulman, E. P., Burns, T. C., Meyer, F. B., O'Neill, B. P., Tran, N. L., Giannini, C., Jenkins, R. B., Parney, I. F. & Sarkaria, J. N., Mar 1 2020, In : Clinical Cancer Research. 26, 5, p. 1094-1104 11 p.

Research output: Contribution to journalArticle

3 Scopus citations

Image-based metric of invasiveness predicts response to adjuvant temozolomide for primary glioblastoma

Massey, S. C., White, H., Whitmire, P., Doyle, T., Johnston, S. K., Singleton, K. W., Jackson, P. R., Hawkins-Daarud, A., Bendok, B. R., Porter, A. B., Vora, S., Sarkaria, J. N., Hu, L. S., Mrugala, M. M. & Swanson, K. R., 2020, In : PloS one. 15, 3, e0230492.

Research output: Contribution to journalArticle

Open Access
1 Scopus citations

Imaging and Dosimetry Study of Inter-fraction Setup Error in a Murine Xenograft Flank Tumor Radiation Model

Smith, E. J., Tryggestad, E. J., Carlson, B. L., Walb, M. C. & Sarkaria, J. N., Feb 1 2020, In : Radiation Research. 193, 2, p. 161-170 10 p.

Research output: Contribution to journalArticle

Localized metabolomic gradients in patient-derived xenograft models of glioblastoma

Randall, E. C., Lopez, B. G. C., Peng, S., Regan, M. S., Abdelmoula, W. M., Basu, S. S., Santagata, S., Yoon, H., Haigis, M. C., Agar, J. N., Tran, N. L., Elmquist, W. F., White, F. M., Sarkaria, J. N. & Agar, N. Y. R., Mar 15 2020, In : Cancer research. 80, 6, p. 1258-1267 10 p.

Research output: Contribution to journalArticle

4 Scopus citations

Patient-derived xenografts of central nervous system metastasis reveal expansion of aggressive minor clones

Tew, B. Y., Legendre, C., Schroeder, M. A., Triche, T., Gooden, G. C., Huang, Y., Butry, L., Ma, D. J., Johnson, K., Martinez, R. A., Pierobon, M., Petricoin, E. F., O'Shaughnessy, J., Osborne, C., Tapia, C., Buckley, D. N., Glen, J., Bernstein, M., Sarkaria, J. N., Toms, S. A. & 1 others, Salhia, B., Jan 11 2020, In : Neuro-oncology. 22, 1, p. 70-83 14 p.

Research output: Contribution to journalArticle

Purine metabolism regulates DNA repair and therapy resistance in glioblastoma

Zhou, W., Yao, Y., Scott, A. J., Wilder-Romans, K., Dresser, J. J., Werner, C. K., Sun, H., Pratt, D., Sajjakulnukit, P., Zhao, S. G., Davis, M., Nelson, B. S., Halbrook, C. J., Zhang, L., Gatto, F., Umemura, Y., Walker, A. K., Kachman, M., Sarkaria, J. N., Xiong, J. & 8 others, Morgan, M. A., Rehemtualla, A., Castro, M. G., Lowenstein, P., Chandrasekaran, S., Lawrence, T. S., Lyssiotis, C. A. & Wahl, D. R., Dec 1 2020, In : Nature communications. 11, 1, 3811.

Research output: Contribution to journalArticle

Open Access

Radiation Induced Metabolic Alterations Associate With Tumor Aggressiveness and Poor Outcome in Glioblastoma

Gupta, K., Vuckovic, I., Zhang, S., Xiong, Y., Carlson, B. L., Jacobs, J., Olson, I., Petterson, X. M., Macura, S. I., Sarkaria, J. & Burns, T. C., May 5 2020, In : Frontiers in Oncology. 10, 535.

Research output: Contribution to journalArticle

Open Access
2019

Automatic 3D Nonlinear Registration of Mass Spectrometry Imaging and Magnetic Resonance Imaging Data

Abdelmoula, W. M., Regan, M. S., Lopez, B. G. C., Randall, E. C., Lawler, S., Mladek, A. C., Nowicki, M. O., Marin, B. M., Agar, J. N., Swanson, K. R., Kapur, T., Sarkaria, J. N., Wells, W. & Agar, N. Y. R., May 7 2019, In : Analytical Chemistry. 91, 9, p. 6206-6216 11 p.

Research output: Contribution to journalArticle

7 Scopus citations

Brain distributional kinetics of a novel MDM2 inhibitor SAR405838: Implications for use in brain tumor therapy

Kim, M., Laramy, J. K., Gampa, G., Parrish, K. E., Brundage, R., Sarkaria, J. N. & Elmquist, W. F., Jan 1 2019, In : Drug Metabolism and Disposition. 47, 12, p. 1403-1414 12 p.

Research output: Contribution to journalArticle

1 Scopus citations

Brain Distribution and Active Efflux of Three panRAF Inhibitors: Considerations in the Treatment of Melanoma Brain Metastases

Gampa, G., Kim, M., Mohammad, A. S., Parrish, K. E., Mladek, A. C., Sarkaria, J. N. & Elmquist, W. F., Mar 1 2019, In : The Journal of pharmacology and experimental therapeutics. 368, 3, p. 446-461 16 p.

Research output: Contribution to journalArticle

Open Access
3 Scopus citations

Brain distribution of a panel of epidermal growth factor receptor inhibitors using cassette dosing in wild-type and ABCB1/ABCG2-deficient mice

Kim, M., Laramy, J. K., Mohammad, A. S., Talele, S., Fisher, J., Sarkaria, J. N. & Elmquist, W. F., Apr 2019, In : Drug Metabolism and Disposition. 47, 4, p. 393-404 12 p.

Research output: Contribution to journalArticle

6 Scopus citations

Chemically Modified Variants of Fenofibrate with Antiglioblastoma Potential

Stalinska, J., Zimolag, E., Pianovich, N. A., Zapata, A., Lassak, A., Rak, M., Dean, M., Ucar-Bilyeu, D., Wyczechowska, D., Culicchia, F., Marrero, L., Del Valle, L., Sarkaria, J., Peruzzi, F., Jursic, B. S. & Reiss, K., Jul 2019, In : Translational Oncology. 12, 7, p. 895-907 13 p.

Research output: Contribution to journalArticle

Open Access
1 Scopus citations

Efficacy of EGFR plus TNF inhibition in a preclinical model of temozolomide-resistant glioblastoma

Guo, G., Gong, K., Puliyappadamba, V. T., Panchani, N., Pan, E., Mukherjee, B., Damanwalla, Z., Bharia, S., Hatanpaa, K. J., Gerber, D. E., Mickey, B. E., Patel, T. R., Sarkaria, J. N., Zhao, D., Burma, S. & Habib, A. A., Dec 1 2019, In : Neuro-oncology. 21, 12, p. 1529-1539 11 p.

Research output: Contribution to journalArticle

Open Access
2 Scopus citations

ENvironmental dynamics underlying responsive extreme survivors (ENDURES) of glioblastoma: A multidisciplinary team-based, multifactorial analytical approach

Johnston, S. K., Whitmire, P., Massey, S. C., Kumthekar, P., Porter, A. B., Raghunand, N., Gonzalez-Cuyar, L. F., Mrugala, M. M., Hawkins-Daarud, A., Jackson, P. R., Hu, L. S., Sarkaria, J. N., Wang, L., Gatenby, R. A., Egan, K. M., Canoll, P. & Swanson, K. R., Aug 1 2019, In : American Journal of Clinical Oncology: Cancer Clinical Trials. 42, 8, p. 655-661 7 p.

Research output: Contribution to journalArticle

Estrogen-related receptor β activation and isoform shifting by cdc2-like kinase inhibition restricts migration and intracranial tumor growth in glioblastoma

Tiek, D. M., Khatib, S. A., Trepicchio, C. J., Heckler, M. M., Divekar, S. D., Sarkaria, J. N., Glasgow, E. & Riggins, R. B., Dec 1 2019, In : FASEB journal : official publication of the Federation of American Societies for Experimental Biology. 33, 12, p. 13476-13491 16 p.

Research output: Contribution to journalArticle

Open Access
2 Scopus citations

Fluorescent reporter assays provide direct, accurate, quantitative measurements of MGMT status in human cells

Nagel, Z. D., Beharry, A. A., Mazzucato, P., Kitange, G. J., Sarkaria, J. N., Kool, E. T. & Samson, L. D., Feb 2019, In : PloS one. 14, 2, e0208341.

Research output: Contribution to journalArticle

Open Access

Hyaluronic acid-functionalized gelatin hydrogels reveal extracellular matrix signals temper the efficacy of erlotinib against patient-derived glioblastoma specimens

Pedron, S., Wolter, G. L., Chen, J. W. E., Laken, S. E., Sarkaria, J. N. & Harley, B. A. C., Oct 2019, In : Biomaterials. 219, 119371.

Research output: Contribution to journalArticle

1 Scopus citations

Inhibition of phosphatidylinositol 3-kinase by PX-866 suppresses temozolomide-induced autophagy and promotes apoptosis in glioblastoma cells

Harder, B. G., Peng, S., Sereduk, C. P., Sodoma, A. M., Kitange, G. J., Loftus, J. C., Sarkaria, J. N. & Tran, N. L., Nov 14 2019, In : Molecular Medicine. 25, 1, 49.

Research output: Contribution to journalArticle

Open Access
3 Scopus citations

Methylation-dependent Tissue Factor Suppression Contributes to the Reduced Malignancy of IDH1-mutant Gliomas

Unruh, D., Mirkov, S., Wray, B., Drumm, M., Lamano, J., Li, Y. D., Haider, Q. F., Javier, R., McCortney, K., Saratsis, A., Scholtens, D. M., Sarkaria, J. N., David James, C. & Horbinski, C., Jan 15 2019, In : Clinical Cancer Research. 25, 2, p. 747-759 13 p.

Research output: Contribution to journalArticle

10 Scopus citations

Molecular profiling of long-term IDH-wildtype glioblastoma survivors

Burgenske, D. M., Yang, J., Decker, P. A., Kollmeyer, T. M., Kosel, M. L., Mladek, A. C., Caron, A. A., Vaubel, R. A., Gupta, S. K., Kitange, G. J., Sicotte, H., Youland, R. S., Remonde, D., Voss, J. S., Fritcher, E. G. B., Kolsky, K. L., Ida, C. M., Meyer, F., Lachance, D. H., Parney, I. J. & 6 others, Kipp, B. R., Giannini, C., Sulman, E. P., Jenkins, R. B., Eckel-Passow, J. E. & Sarkaria, J. N., Nov 4 2019, In : Neuro-oncology. 21, 11, p. 1458-1469 12 p.

Research output: Contribution to journalArticle

5 Scopus citations

Pathogenic Germ Line Variants in a Patient With Severe Toxicity From Breast Radiotherapy

Wilhite, T. J., Youland, R. S., Tian, S., Finley, R. R., Sarkaria, J. N. & Corbin, K. S., Jan 1 2019, In : Clinical breast cancer.

Research output: Contribution to journalArticle

Phase I-II trial of imatinib mesylate (Gleevec; STI571) in treatment of recurrent oligodendroglioma and mixed oligoastrocytoma. North central cancer treatment group study N0272 (ALLIANCE/NCCTG)

Jaeckle, K. A., Anderson, S. K., Twohy, E. L., Dixon, J. G., Giannini, C., Jenkins, R., Egorin, M. J., Sarkaria, J. N., Brown, P. D., Flynn, P. J., Schwerkoske, J., Buckner, J. C. & Galanis, E., Jul 1 2019, In : Journal of neuro-oncology. 143, 3, p. 573-581 9 p.

Research output: Contribution to journalArticle

Quantifying the setup uncertainty of a stereotactic murine micro-image guided radiation therapy system

Walb, M. C., Carlson, B. L., Sarkaria, J. N. & Tryggestad, E. J., 2019, In : British Journal of Radiology. 92, 1095, 20180487.

Research output: Contribution to journalArticle

3 Scopus citations

Temozolomide sensitizes MGMT-deficient tumor cells to ATR inhibitors

Jackson, C. B., Noorbakhsh, S. I., Sundaram, R. K., Kalathil, A. N., Ganesa, S., Jia, L., Breslin, H., Burgenske, D. M., Gilad, O., Sarkaria, J. N. & Bindra, R. S., Sep 1 2019, In : Cancer research. 79, 17, p. 4331-4338 8 p.

Research output: Contribution to journalArticle

4 Scopus citations

The medical necessity of advanced molecular testing in the diagnosis and treatment of brain tumor patients

Horbinski, C., Ligon, K. L., Brastianos, P., Huse, J. T., Venere, M., Chang, S., Buckner, J., Cloughesy, T., Jenkins, R. B., Giannini, C., Nabors, L. B., Wen, P. Y., Aldape, K. J., Lukas, R. V., Galanis, E., Eberhart, C. G., Brat, D. J. & Sarkaria, J. N., Dec 1 2019, In : Neuro-oncology. 21, 12, p. 1498-1508 11 p.

Research output: Contribution to journalArticle

Open Access
6 Scopus citations

Xenograft-based, platform-independent gene signatures to predict response to alkylating chemotherapy, radiation, and combination therapy for glioblastoma

Zhao, S. G., Yu, M., Spratt, D. E., Chang, S. L., Feng, F. Y., Kim, M. M., Speers, C. W., Carlson, B. L., Mladek, A. C., Lawrence, T. S., Sarkaria, J. N. & Wahl, D. R., Sep 6 2019, In : Neuro-oncology. 21, 9, p. 1141-1149 9 p.

Research output: Contribution to journalArticle

4 Scopus citations
2018

A novel enhancer regulates MGMT expression and promotes temozolomide resistance in glioblastoma

Chen, X., Zhang, M., Gan, H., Wang, H., Lee, J. H., Fang, D., Kitange, G. J., He, L., Hu, Z., Parney, I. F., Meyer, F. B., Giannini, C., Sarkaria, J. N. & Zhang, Z., Dec 1 2018, In : Nature communications. 9, 1, 2949.

Research output: Contribution to journalArticle

38 Scopus citations

A PDGFRα-driven mouse model of glioblastoma reveals a stathmin1-mediated mechanism of sensitivity to vinblastine

Jun, H. J., Appleman, V. A., Wu, H. J., Rose, C. M., Pineda, J. J., Yeo, A. T., Delcuze, B., Lee, C., Gyuris, A., Zhu, H., Woolfenden, S., Bronisz, A., Nakano, I., Chiocca, E. A., Bronson, R. T., Ligon, K. L., Sarkaria, J. N., Gygi, S. P., Michor, F., Mitchison, T. J. & 1 others, Charest, A., Dec 1 2018, In : Nature communications. 9, 1, 3116.

Research output: Contribution to journalArticle

5 Scopus citations

ATR inhibition is a promising radiosensitizing strategy for triple-negative breast cancer

Tu, X., Kahila, M. M., Zhou, Q., Yu, J., Kalari, K. R., Wang, L., Harmsen, W. S., Yuan, J., Boughey, J. C., Goetz, M. P., Sarkaria, J. N., Lou, Z. & Mutter, R. W., Nov 2018, In : Molecular cancer therapeutics. 17, 11, p. 2462-2472 11 p.

Research output: Contribution to journalArticle

13 Scopus citations

Brain distribution of a novel MEK Inhibitor E6201: Implications in the treatment of melanoma brain metastases

Gampa, G., Kim, M., Cook-Rostie, N., Laramy, J. K., Sarkaria, J. N., Paradiso, L., DePalatis, L. & Elmquist, W. F., May 2018, In : Drug Metabolism and Disposition. 46, 5, p. 658-666 9 p.

Research output: Contribution to journalArticle

10 Scopus citations

Constitutive interferon pathway activation in tumors as an efficacy determinant following oncolytic virotherapy

Kurokawa, C., Iankov, I. D., Anderson, S. K., Aderca, I., Leontovich, A. A., Maurer, M. J., Oberg, A. L., Schroeder, M. A., Giannini, C., Greiner, S. M., Becker, M. A., Thompson, E. A., Haluska, P., Jentoft, M. E., Parney, I. F., Weroha, S. J., Jen, J., Sarkaria, J. N. & Galanis, E., 2018, In : Journal of the National Cancer Institute. 110, 10, djy033.

Research output: Contribution to journalArticle

20 Scopus citations

Distinctive epigenomes characterize glioma stem cells and their response to differentiation cues

Zhou, D., Alver, B. M., Li, S., Hlady, R. A., Thompson, J. J., Schroeder, M. A., Lee, J. H., Qiu, J., Schwartz, P. H., Sarkaria, J. N. & Robertson, K. D., Mar 27 2018, In : Genome biology. 19, 1, 43.

Research output: Contribution to journalArticle

18 Scopus citations

Drug and disease signature integration identifies synergistic combinations in glioblastoma

Stathias, V., Jermakowicz, A. M., Maloof, M. E., Forlin, M., Walters, W., Suter, R. K., Durante, M. A., Williams, S. L., Harbour, J. W., Volmar, C. H., Lyons, N. J., Wahlestedt, C., Graham, R. M., Ivan, M. E., Komotar, R. J., Sarkaria, J. N., Subramanian, A., Golub, T. R., Schürer, S. C. & Ayad, N. G., Dec 1 2018, In : Nature communications. 9, 1, 5315.

Research output: Contribution to journalArticle

11 Scopus citations

Efficacy of the MDM2 inhibitor SAR405838 in glioblastoma is limited by poor distribution across the blood–brain barrier

Kim, M., Ma, D. J., Calligaris, D., Zhang, S., Feathers, R. W., Vaubel, R. A., Meaux, I., Mladek, A. C., Parrish, K. E., Jin, F., Barriere, C., Debussche, L., Watters, J., Tian, S., Decker, P. A., Eckel-Passow, J. E., Kitange, G. J., Johnson, A. J., Parney, I. F., Anastasiadis, P. Z. & 3 others, Agar, N. Y. R., Elmquist, W. F. & Sarkaria, J. N., Sep 2018, In : Molecular cancer therapeutics. 17, 9, p. 1893-1901 9 p.

Research output: Contribution to journalArticle

6 Scopus citations

H3.3K27M mutant proteins reprogram epigenome by sequestering the PRC2 complex to poised enhancers

Fang, D., Gan, H., Cheng, L., Lee, J. H., Zhou, H., Sarkaria, J. N., Daniels, D. J. & Zhang, Z., Jun 22 2018, In : eLife. 7, e36696.

Research output: Contribution to journalArticle

20 Scopus citations

Hypoxia-inducible factor 2α: A novel target in gliomas

Renfrow, J. J., Soike, M. H., Debinski, W., Ramkissoon, S. H., Mott, R. T., Frenkel, M. B., Sarkaria, J. N., Lesser, G. J. & Strowd, R. E., Sep 2018, In : Future Medicinal Chemistry. 10, 18, p. 2227-2236 10 p.

Research output: Contribution to journalArticle

5 Scopus citations
1 Scopus citations

Influence of hyaluronic acid transitions in tumor microenvironment on glioblastoma malignancy and invasive behavior

Chen, J. W. E., Pedron, S., Shyu, P., Hu, Y., Sarkaria, J. N. & Harley, B. A. C., Jun 26 2018, In : Frontiers in Materials. 5, 39.

Research output: Contribution to journalArticle

Open Access
10 Scopus citations

Integrated mapping of pharmacokinetics and pharmacodynamics in a patient-derived xenograft model of glioblastoma

Randall, E. C., Emdal, K. B., Laramy, J. K., Kim, M., Roos, A., Calligaris, D., Regan, M. S., Gupta, S. K., Mladek, A. C., Carlson, B. L., Johnson, A. J., Lu, F. K., Xie, X. S., Joughin, B. A., Reddy, R. J., Peng, S., Abdelmoula, W. M., Jackson, P. R., Kolluri, A., Kellersberger, K. A. & 8 others, Agar, J. N., Lauffenburger, D. A., Swanson, K. R., Tran, N. L., Elmquist, W. F., White, F. M., Sarkaria, J. N. & Agar, N. Y. R., Dec 1 2018, In : Nature communications. 9, 1, 4904.

Research output: Contribution to journalArticle

16 Scopus citations

Is the blood-brain barrier really disrupted in all glioblastomas? A critical assessment of existing clinical data

Sarkaria, J. N., Hu, L. S., Parney, I. F., Pafundi, D. H., Brinkmann, D. H., Laack, N. N., Giannini, C., Burns, T. C., Kizilbash, S. H., Laramy, J. K., Swanson, K. R., Kaufmann, T. J., Brown, P. D., Agar, N. Y. R., Galanis, E., Buckner, J. C. & Elmquist, W. F., Jan 22 2018, In : Neuro-oncology. 20, 2, p. 184-191 8 p.

Research output: Contribution to journalArticle

84 Scopus citations

LPA signaling is regulated through the primary cilium: A novel target in glioblastoma

Loskutov, Y. V., Griffin, C. L., Marinak, K. M., Bobko, A., Margaryan, N. V., Geldenhuys, W. J., Sarkaria, J. N. & Pugacheva, E. N., Mar 1 2018, In : Oncogene. 37, 11, p. 1457-1471 15 p.

Research output: Contribution to journalArticle

14 Scopus citations

Modeling the diffusion of D-2-hydroxyglutarate from IDH1 mutant gliomas in the central nervous system

Linninger, A., Hartung, G. A., Liu, B. P., Mirkov, S., Tangen, K., Lukas, R. V., Unruh, D., David James, C., Sarkaria, J. N. & Horbinski, C., 2018, In : Neuro-oncology. 20, 9, p. 1197-1206 10 p.

Research output: Contribution to journalArticle

7 Scopus citations

Molecular and structural traits of insulin receptor substrate 1/LC3 nuclear structures and their role in autophagy control and tumor cell survival

Lassak, A., Dean, M., Wyczechowsk, D., Wilk, A., Marrero, L., Trillo-Tinoco, J., Hamid Boulares, A., Sarkaria, J. N., Valle, L. D., Peruzzi, F., Ochoa, A. & Reiss, K., May 1 2018, In : Molecular and cellular biology. 38, 10, e00608.

Research output: Contribution to journalArticle

2 Scopus citations

NOTCH3 expression is linked to breast cancer seeding and distant metastasis

Leontovich, A. A., Jalalirad, M., Salisbury, J. L., Mills, L., Haddox, C., Schroeder, M., Tuma, A., Guicciardi, M. E., Zammataro, L., Gambino, M. W., Amato, A., Di Leonardo, A., McCubrey, J., Lange, C. A., Liu, M., Haddad, T., Goetz, M., Boughey, J., Sarkaria, J., Wang, L. & 3 others, Ingle, J. N., Galanis, E. & D'Assoro, A. B., Sep 4 2018, In : Breast Cancer Research. 20, 1, 105.

Research output: Contribution to journalArticle

14 Scopus citations

Pharmacokinetic assessment of cooperative efflux of the multitargeted kinase inhibitor ponatinib across the blood-brain barrier

Laramy, J. K., Kim, M., Parrish, K. E., Sarkaria, J. N. & Elmquist, W. F., May 2018, In : Journal of Pharmacology and Experimental Therapeutics. 365, 2, p. 249-261 13 p.

Research output: Contribution to journalArticle

4 Scopus citations

Phase 1/2 trial of temsirolimus and sorafenib in the treatment of patients with recurrent glioblastoma: North Central Cancer Treatment Group Study/Alliance N0572

Schiff, D., Jaeckle, K. A., Anderson, S. K., Galanis, E., Giannini, C., Buckner, J. C., Stella, P., Flynn, P. J., Erickson, B. J., Schwerkoske, J. F., Kaluza, V., Twohy, E., Dancey, J., Wright, J. & Sarkaria, J. N., Apr 1 2018, In : Cancer. 124, 7, p. 1455-1463 9 p.

Research output: Contribution to journalArticle

10 Scopus citations

Phase I/II trial of vorinostat combined with temozolomide and radiation therapy for newly diagnosed glioblastoma: Results of Alliance N0874/ABTC 02

Galanis, E., Keith Anderson, S., Miller, C. R., Sarkaria, J. N., Jaeckle, K., Buckner, J. C., Ligon, K. L., Ballman, K. V., Moore, D. F., Nebozhyn, M., Loboda, A., Schiff, D., Ahluwalia, M. S., Lee, E. Q., Gerstner, E. R., Lesser, G. J., Prados, M., Grossman, S. A., Cerhan, J., Giannini, C. & 1 others, Wen, P. Y., Mar 27 2018, In : Neuro-oncology. 20, 4, p. 546-556 11 p.

Research output: Contribution to journalArticle

18 Scopus citations

Presence of stromal cells in a bioengineered tumor microenvironment alters glioblastoma migration and response to STAT3 inhibition

Marisol Herrera-Perez, R., Voytik-Harbin, S. L., Sarkaria, J. N., Pollok, K. E., Fishel, M. L. & Rickus, J. L., Mar 2018, In : PloS one. 13, 3, e0194183.

Research output: Contribution to journalArticle

11 Scopus citations